Immunohematology Market Analysis 2025–2029: Growth Forecast and Competitive Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the immunohematology market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Immunohematology Market Be Worth By 2029, And What CAGR Will It Achieve?

The immunohematology market has experienced steady growth in recent years. It is anticipated to expand from $2.46 billion in 2024 to $2.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.6%. The market’s historical growth can be attributed to improvements in blood transfusion science, the widespread occurrence of blood disorders, the expansion of blood banks, government-led blood safety initiatives, an increase in surgical operations, and greater awareness of risks related to transfusions.

The immunohematology market is projected to demonstrate significant expansion over the next few years. It is forecast to reach $3.17 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.7%. This growth during the forecast period is primarily driven by factors such as the increasing requirement for point-of-care testing, the introduction of novel blood products, the expansion of healthcare infrastructure, the use of genetic testing for blood compatibility, and regulatory frameworks supporting blood safety. Noteworthy trends anticipated in the forecast period include the adoption of automation and high-throughput systems, advancements in molecular blood typing methods, enhanced antibody detection techniques, the implementation of patient blood management programs, the integration of AI in analysis, and the broader incorporation of telemedicine.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Which Factors Are Driving The Immunohematology Market Forward?

The increasing prevalence of hematological disorders is anticipated to propel the expansion of the immunohematology market in the coming years. Hematological disorders represent a diverse range of conditions impacting the blood and its various components, such as red blood cells, white blood cells, platelets, and plasma. Immunohematology is vital for ensuring safe and effective blood transfusions by helping to prevent adverse reactions caused by incompatible blood types or the presence of antibodies in the recipient’s blood. Furthermore, immunohematology techniques are utilized for the diagnosis and treatment of immune system-related diseases that may affect the hematological system. For instance, according to Cancer Research UK, a UK-based research organization, the average number of new leukemia cases caused by hematological disorders in the UK is expected to climb from roughly 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Therefore, the rising prevalence rate of hematological disorders is driving the growth of the immunohematology market.

Which Segments Form The Key Structure Of The Immunohematology Market?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Strategic Shifts And Innovations Are Influencing The Immunohematology Market?

Leading companies in the immunohematology market are prioritizing the creation of advanced diagnostic solutions, such as soluble recombinant proteins, designed to counteract the interference of the cancer therapy daratumumab. A soluble recombinant protein is one created using recombinant DNA technology that maintains its correct folding and function in a soluble state within a host cell or solution, making it suitable for research and therapeutic uses. As an illustration, in November 2023, Grifols, S.A., a Spain-based pharmaceutical company, launched its Grifols sCD38 solution. Grifols’ sCD38 is the pioneering soluble recombinant protein, specifically developed to address interference from the cancer therapy daratumumab during crucial blood transfusion compatibility testing. This innovative solution, tailored for multiple myeloma patients, works by preventing daratumumab from attaching to CD38 proteins on red blood cells, thereby ensuring accurate pre-transfusion test outcomes. By streamlining screening, identification, and crossmatching procedures, Grifols sCD38 enhances blood transfusion protocols and significantly reduces delays in delivering vital transfusions.

Which Firms Are Making The Biggest Impact In The Immunohematology Market?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Is Expected To Lead The Immunohematology Market In The Next Few Years?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

Browse Through More Reports Similar to the Global Immunohematology Market 2025, By The Business Research Company

Out Of Home Advertising Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/out-of-home-advertising-global-market-report

Print Advertising Distribution Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/print-advertising-distribution-global-market-report

Print Advertising Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/print-advertising-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795